‘Astounding’ second-chance cancer drug heading for FDA approval – CNN
CNN |
'Astounding' second-chance cancer drug heading for FDA approval
CNN CAR–T drugs like tisagenlecleucel are made by removing immune cells from a patient, genetically modifying them using a virus and putting them back into the patient. The virus creates a new cell receptor — which is, in Novartis' case, part mouse … |
